Cachexia: Prevalence and impact in medicine

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 11, Issue 4, 2008, Pages 400-407

  Tan, Benjamin H L ^a   Fearon, Kenneth C H ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Cachexia; Chronic diseases; Impact; Prevalence; Reverse epidemiology

Indexed keywords

CACHEXIA; CHRONIC DISEASE; CHRONIC KIDNEY DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DECREASED APPETITE; HEART FAILURE; HUMAN; INFLAMMATION; MORBIDITY; MORTALITY; MUSCLE ATROPHY; NEOPLASM; OBESITY; PREVALENCE; PUBLIC HEALTH PROBLEM; QUALITY OF LIFE; REVIEW; SURVIVAL; WEIGHT REDUCTION; PUBLIC HEALTH;

CACHEXIA; CHRONIC DISEASE; HUMANS; INFLAMMATION; MUSCULAR ATROPHY; OBESITY; PREVALENCE; PUBLIC HEALTH; QUALITY OF LIFE;

EID: 54049125762     PISSN: 13631950     EISSN: 15353885     Source Type: Journal    
DOI: 10.1097/MCO.0b013e328300ecc1     Document Type: Review

References (43)

1. Morley JE, Thomas DR, Wilson MM. Cachexia: pathophysiology and clinical relevance. Am J Clin Nutr 2006; 83:735-743.
2. Fearon KC, Voss AC, Hustead DS. Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. Am J Clin Nutr 2006; 83:1345-1350.
3. Segura A, Pardo J, Jara C, et al. An epidemiological evaluation of the prevalence of malnutrition in Spanish patients with locally advanced or metastatic cancer. Clin Nutr 2005; 24:801-814.
4. Schols AM, Broekhuizen R, Weling-Scheepers CA, et al. Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr 2005; 82:53-59.
5. Anker SD, NegassaA, Coats AJ, et al. Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet 2003; 361:1077-1083.
6. Kalantar-Zadeh K, Kopple JD, Humphreys MH, et al. Comparing outcome predictability of markers of malnutrition-inflammation complex syndrome in haemodialysis patients. Nephrol Dial Transplant 2004; 19:1507-1519.
7. Kalantar-Zadeh K, Horwich TB, Oreopoulos A, et al. Risk factor paradox in wasting diseases. Curr Opin Clin Nutr Metab Care 2007; 10:433-442.
8. Teunissen SC, Wesker W, Kruitwagen C, et al. Symptom prevalence in patients with incurable cancer: a systematic review. J Pain Symptom Manage 2007; 34:94-104.
9. Irigaray P, Newby JA, Lacomme S, et al. Overweight/obesity and cancer genesis: more than a biological link. Biomed Pharmacother 2007; 61:665-678.
10. Roubenoff R. Sarcopenic obesity: the confluence of two epidemics. Obes Res 2004; 12:887-888.
11. Skipworth RJ, Stewart GD, Dejong CH, et al. Pathophysiology of cancer cachexia: much more than host-tumour interaction? Clin Nutr 2007; 26:667-676.
12. DeWys WD, Begg C, Lavin PT, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 1980; 69:491-497.
13. American Heart Association. Heart disease and stroke statistics- 2008 update. Dallas, TX: American Heart Association; 2008. http://www.ameri-canheart. org/presenter.jhtml?identifier=3037327.
14. von Haehling S, Doehner W, Anker SD. Nutrition, metabolism, and the complex pathophysiology of cachexia in chronic heart failure. Cardiovasc Res 2007; 73:298-309.
15. Anker SD, Ponikowski P, Varney S, et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet 1 997; 349:1050-1053.
16. American Lung Association. Chronic obstructive pulmonary disease (COPD) fact sheet; 2006. New York, NY: American Lung Association. http://www.lun-gusa. org/site/pp.asp?c=dvLUK9O0E&b=35020.
17. Wouters EF. Chronic obstructive pulmonary disease (COPD) and treatment of COPD-related cachexia. In: Mantovani G, editor. Cachexia and wasting: a modern approach. Italy: Springer; 2006. pp. 339-348.
18. Vermeeren MA, Creutzberg EC, Schols AM, et al. Prevalence of nutritional depletion in a large out-patient population of patients with COPD. Respir Med 2006; 100:1349-1355.
19. Koehler F, Doehner W, Hoernig S, et al. Anorexia in chronic obstructive pulmonary disease - association to cachexia and hormonal derangement. Int J Cardiol 2007; 119:83-89.
20. Creutzberg EC, Wouters EF, Mostert R, et al. Efficacy of nutritional supplementation therapy in depleted patients with chronic obstructive pulmonary disease. Nutrition 2003; 19:120-127.
21. Lysaght MJ. Maintenance dialysis population dynamics: current trends and long-term implications. J Am Soc Nephrol 2002; 13 (Suppl 1):S37-S40.
22. Kalantar-Zadeh K, Ikizler TA, Block G, et al. Malnutrition- inflammation complex syndrome in dialysis patients: causes and consequences. Am J Kidney Dis 2003; 42:864-881.
23. Kalantar-Zadeh K. Recent advances in understanding the malnutrition-inflammation-cachexia syndrome in chronic kidney disease patients: what is next? Semin Dial 2005; 18:365-369.
24. Mak RH, Cheung W. Cachexia in chronic kidney disease: role of inflammation and neuropeptide signaling. Curr Opin Nephrol Hypertens 2007; 16:27-31.
25. Deans DA, Wigmore SJ, de Beaux AC, et al. Clinical prognostic scoring system to aid decision-making in gastro-oesophageal cancer. Br J Surg 2007; 94:1501-1508.
26. Cleveland RJ, Eng SM, Abrahamson PE, et al. Weight gain prior to diagnosis and survival from breast cancer. Cancer Epidemiol Biomarkers Prev 2007; 16:1803-1811.
27. Kovesdy CP, Anderson JE, Kalantar-Zadeh K. Paradoxical association between body mass index and mortality in men with CKD not yet on dialysis. Am J Kidney Dis 2007; 49:581-591.
28. Hinsley R, Hughes R. 'The reflections you get': an exploration of body image and cachexia. Int J Palliat Nurs 2007; 13:84-89.
29. Fouladiun M, Korner U, Gunnebo L, et al. Daily physical-rest activities in relation to nutritional state, metabolism, and quality of life in cancer patients with progressive cachexia. Clin Cancer Res 2007; 13:6379-6385.
30. Conraads VM, Hoymans VY, Vrints CJ. Heart failure and cachexia: insights offered from molecular biology. Front Biosci 2008; 13:325-335.
31. Kalantar-Zadeh K, Fouque D, Kopple JD. Outcome research, nutrition, and reverse epidemiology in maintenance dialysis patients. J Ren Nutr 2004; 14:64-71.
32. Katsura H, Yamada K, Kida K. Both generic and disease specific health-related quality of life are deteriorated in patients with underweight COPD. Respir Med 2005; 99:624-630.
33. Dahele M, Skipworth RJ, Wall L, et al. Objective physical activity and self-reported quality of life in patients receiving palliative chemotherapy. J Pain Symptom Manage 2007; 33:676-685.
34. Ross PJ, Ashley S, Norton A, et al. Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers? Br J Cancer 2004; 90:1905-1911.
35. McKelvie RS. Exercise training in patients with heart failure: clinical outcomes, safety, and indications. Heart Fail Rev 2008; 13:3-11.
36. Hopkinson NS, Man WD, Dayer MJ, et al. Acute effect of oral steroids on muscle function in chronic obstructive pulmonary disease. Eur Respir J 2004; 24:137-142.
37. Wei M, Bargman JM, Oreopoulos DG. Factors related to erythropoietin hypo-responsiveness in patients on chronic peritoneal dialysis. Int Urol Nephrol 2007; 39:935-940.
38. U.S. Renal Data System, USRDS 2007 annual data report. Atlas of chronic kidney disease and end-stage renal disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2007. http://www.usrds.org/adr. htm.
39. American Cancer Society. Cancer facts & figures 2007. Atlanta: American Cancer Society; 2007. http://www.cancer.org/docroot/stt/stt-0.asp.
40. Knudtson MD, Klein BE, Klein R, et al. Associations with weight loss and subsequent mortality risk. Ann Epidemiol 2005; 15:483-491.
41. Collins N. Protein-energy malnutrition and involuntary weight loss: nutritional and pharmacological strategies to enhance wound healing. Expert Opin Pharmacother 2003; 4:1121-1140.
42. Stevens JA, Corso PS, Finkelstein EA, et al. The costs of fatal and nonfatal falls among older adults. Inj Prev 2006; 12:290-295.
43. Kumar RN, Gupchup GV, Dodd MA, et al. Direct healthcare costs of 4 common skin ulcers in New Mexico Medicaid fee-for-service patients. Adv Skin Wound Care 2004; 17:143-149.